← Back to Dashboard

Labyrinthopeptin A2

viral membrane lipid phosphatidylethanolamine

2D Structure

Loading structure...

3D Structure

Loading 3D structure...

Chemical Identifiers

C1=NC(=C2C(=N1)N(C=N2)C3C(C(C(O3)COP(=O)(O)OC4C(C(OC4N5C=NC6=C(N=CN=C6…
FYGMROUKBQAUFB-CCKJNKNQSA-N
ClinicalTrials.govPubMed

Clinical Development by Virus9

Dengue virus
DENV
Target: Viral membrane
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:31666384
Chikungunya virus
CHIKV
Target: Viral membrane
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:31666384
Human betaherpesvirus 5
CMV
Target: Viral membrane
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:31666384
Hepacivirus C
HCV
Target: Viral membrane
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:31666384
Human alphaherpesvirus 1
HSV-1
Target: Viral membrane
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:31666384
Human alphaherpesvirus 2
HSV-2
Target: Viral membrane
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:31666384
Human gammaherpesvirus 8
KSHV
Target: Viral membrane
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:31666384
West Nile virus
WNV
Target: Viral membrane
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:31666384
Zika virus
ZIKV
Target: Viral membrane
Preclinical
Preclinical
Phase 2
Phase 3
Approved
PMID:31666384